109 related articles for article (PubMed ID: 1658509)
1. Cross-tolerance studies in the spinal cord of beta-FNA-treated mice provides further evidence for delta opioid receptor subtypes.
Sofuoglu M; Portoghese PS; Takemori AE
Life Sci; 1991; 49(19):PL153-6. PubMed ID: 1658509
[TBL] [Abstract][Full Text] [Related]
2. Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes.
Sofuoglu M; Portoghese PS; Takemori AE
J Pharmacol Exp Ther; 1991 May; 257(2):676-80. PubMed ID: 1851833
[TBL] [Abstract][Full Text] [Related]
3. 7-Benzylidenenaltrexone (BNTX): a selective delta 1 opioid receptor antagonist in the mouse spinal cord.
Sofuoglu M; Portoghese PS; Takemori AE
Life Sci; 1993; 52(8):769-75. PubMed ID: 8383271
[TBL] [Abstract][Full Text] [Related]
4. Antinociception and delta-1 opioid receptors in the rat spinal cord: studies with intrathecal 7-benzylidenenaltrexone.
Hammond DL; Stewart PE; Littell L
J Pharmacol Exp Ther; 1995 Sep; 274(3):1317-24. PubMed ID: 7562504
[TBL] [Abstract][Full Text] [Related]
5. Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice.
Heyman JS; Mulvaney SA; Mosberg HI; Porreca F
Brain Res; 1987 Sep; 420(1):100-8. PubMed ID: 2823970
[TBL] [Abstract][Full Text] [Related]
6. Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice.
Szentirmay AK; Király KP; Lenkey N; Lackó E; Al-Khrasani M; Friedmann T; Timár J; Gyarmati S; Tóth G; Fürst S; Riba P
Brain Res Bull; 2013 Jan; 90():66-71. PubMed ID: 22995282
[TBL] [Abstract][Full Text] [Related]
7. Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.
He L; Lee NM
J Pharmacol Exp Ther; 1998 Jun; 285(3):1181-6. PubMed ID: 9618421
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of dose-dependent antagonism by beta-funaltrexamine of the antinociceptive effects of intrathecal mu agonists.
Mjanger E; Yaksh TL
J Pharmacol Exp Ther; 1991 Aug; 258(2):544-50. PubMed ID: 1650833
[TBL] [Abstract][Full Text] [Related]
9. Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin.
Stewart PE; Hammond DL
J Pharmacol Exp Ther; 1993 Aug; 266(2):820-8. PubMed ID: 8394918
[TBL] [Abstract][Full Text] [Related]
10. Selective antagonism by naltrindole of the antinociceptive effects of the delta opioid agonist cyclic[D-penicillamine2-D-penicillamine5]enkephalin in the rat.
Drower EJ; Stapelfeld A; Rafferty MF; de Costa BR; Rice KC; Hammond DL
J Pharmacol Exp Ther; 1991 Nov; 259(2):725-31. PubMed ID: 1658309
[TBL] [Abstract][Full Text] [Related]
11. Spinal opioid delta antinociception in the mouse: mediation by a 5'-NTII-sensitive delta receptor subtype.
Mattia A; Farmer SC; Takemori AE; Sultana M; Portoghese PS; Mosberg HI; Bowen WD; Porreca F
J Pharmacol Exp Ther; 1992 Feb; 260(2):518-25. PubMed ID: 1310737
[TBL] [Abstract][Full Text] [Related]
12. Delta receptor involvement in morphine suppression of noxiously evoked activity of spinal WDR neurons in cats.
Omote K; Kitahata LM; Nakatani K; Collins JG
Brain Res; 1991 Jul; 554(1-2):299-303. PubMed ID: 1657291
[TBL] [Abstract][Full Text] [Related]
13. Continuous intrathecal opioid analgesia: tolerance and cross-tolerance of mu and delta spinal opioid receptors.
Russell RD; Leslie JB; Su YF; Watkins WD; Chang KJ
J Pharmacol Exp Ther; 1987 Jan; 240(1):150-8. PubMed ID: 3027302
[TBL] [Abstract][Full Text] [Related]
14. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
Liu-Chen LY; Yang HH; Li S; Adams JU
J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
[TBL] [Abstract][Full Text] [Related]
15. Effects of intracerebroventricular beta-funaltrexamine on mu and delta opioid receptors in the rat: dichotomy between binding and antinociception.
Liu-Chen LY; Li SX; Wheeler-Aceto H; Cowan A
Eur J Pharmacol; 1991 Oct; 203(2):195-202. PubMed ID: 1666046
[TBL] [Abstract][Full Text] [Related]
16. Different mu receptor subtypes mediate spinal and supraspinal analgesia in mice.
Paul D; Bodnar RJ; Gistrak MA; Pasternak GW
Eur J Pharmacol; 1989 Sep; 168(3):307-14. PubMed ID: 2555205
[TBL] [Abstract][Full Text] [Related]
17. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.
Jiang Q; Takemori AE; Sultana M; Portoghese PS; Bowen WD; Mosberg HI; Porreca F
J Pharmacol Exp Ther; 1991 Jun; 257(3):1069-75. PubMed ID: 1646319
[TBL] [Abstract][Full Text] [Related]
18. Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes.
Mattia A; Vanderah T; Mosberg HI; Porreca F
J Pharmacol Exp Ther; 1991 Aug; 258(2):583-7. PubMed ID: 1650835
[TBL] [Abstract][Full Text] [Related]
19. Modulation of mu-mediated antinociception by delta agonists: characterization with antagonists.
Heyman JS; Jiang Q; Rothman RB; Mosberg HI; Porreca F
Eur J Pharmacol; 1989 Oct; 169(1):43-52. PubMed ID: 2557223
[TBL] [Abstract][Full Text] [Related]
20. The effect of pretreatment with a delta 2-opioid receptor antisense oligodeoxynucleotide on the recovery from acute antinociceptive tolerance to delta 2-opioid receptor agonist in the mouse spinal cord.
Narita M; Mizoguchi H; Kampine JP; Tseng LF
Br J Pharmacol; 1997 Feb; 120(4):587-92. PubMed ID: 9051295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]